| LAZJEEVO JOHNSON & JOHNSON
2206981 31 Aug 2022 | on 05 Jul 2024 | Class 005 Class 005 Pharmaceutical Products Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases and digital ulcers; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; human pharmaceuticals preparations, namely anxiolytic medications, anti-virals, anti-inflammatories, anti-infectives, anti-allergic medications, and vaccines; human pharmaceutical preparations for the relief of pain | | | LAZJEVY JOHNSON & JOHNSON
2096160 31 Mar 2021 | on 07 Jun 2023 | Class 005 Class 005 Pharmaceutical Products Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases and digital ulcers; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; human pharmaceuticals preparations, namely anxiolytic medications, anti-virals, anti-inflammatories, anti-infectives, anti-allergic medications, and vaccines; human pharmaceutical preparations for the relief of pain | | 
